Latest Biotech News

U.S. health officials revised the federal childhood immunization schedule, narrowing routine recommendations and moving several vaccines to risk‑based or shared‑decision categories. The Centers...

OpenAI launched ChatGPT Health, a dedicated offering for health-related conversations designed to help users navigate personal health information rather than provide diagnoses. The company invited...

Rakuten Medical closed a $100 million financing round to support its photoimmunotherapy platform and an ongoing Phase III trial, with company statements indicating a targeted regulatory filing...

Sophia Genetics and MD Anderson announced a collaboration to co‑develop an NGS‑based oncology assay and AI-driven bioinformatics pipelines to interpret RNA‑seq and multiomic cancer data, with the...

Eli Lilly agreed to buy Ventyx Biosciences for $1.2 billion to add an oral NLRP3 inhibitor to its inflammation and metabolic portfolio. Ventyx’s lead candidate, VTX3232, showed biomarker and...

GSK and development partner Ionis reported positive top-line results from two pivotal Phase 3 studies of bepirovirsen, an antisense oligonucleotide aimed at functional cure for chronic hepatitis...

Amgen struck multiple European deals to bolster its oncology pipeline, including an acquisition of Dark Blue Therapeutics and a license from Disco Pharmaceuticals. The transactions total up to...

Alumis reported positive Phase 3 results for envudeucitinib, a selective oral TYK2 inhibitor, meeting co‑primary endpoints in two pivotal psoriasis studies. The company said the trials showed high...

Arrowhead Pharmaceuticals disclosed early clinical signals from RNAi programs targeting adipose biology that, when paired with Lilly’s tirzepatide (Zepbound), produced larger fat and weight...

Sanofi signed a multi‑year collaboration with Earendil Labs valued up to $2.56 billion to discover bispecific antibodies for autoimmune diseases using Earendil’s AI platform. The pact includes...

Two preclinical immuno‑oncology advances surfaced this week. A Nature Communications study showed Boron Neutron Capture Therapy (BNCT) can preserve immune cell integrity while eliciting anti‑tumor...

Academic and industry groups reported gene‑therapy advances in two distinct domains. University of Pennsylvania researchers published in Nature a cortical gene‑therapy approach that mimics opioid...

AI‑driven discovery activity accelerated with two notable developments. Insilico Medicine signed an $888 million collaboration with Servier to discover oncology candidates using its AI platforms....

Federal health authorities moved to reduce the number of routinely recommended childhood vaccines, shifting several shots to targeted or shared‑decision categories. The change—announced by HHS and...

GSK and Ionis announced positive topline results from two pivotal Phase 3 trials (B‑Well 1 and B‑Well 2) of bepirovirsen, an antisense oligonucleotide designed to drive functional cures in chronic...

GSK struck a multi‑year strategic collaboration with Helix to access GenoSphere, Helix’s clinico‑genomic database of whole‑exome sequencing linked to longitudinal medical, pharmacy and mortality...

Alumis reported that envudeucitinib, its oral TYK2 inhibitor, met primary and key secondary endpoints across two Phase 3 trials in moderate‑to‑severe plaque psoriasis. The company said results...

Amgen agreed to acquire U.K. oncology startup Dark Blue Therapeutics in a deal worth up to $840 million, gaining preclinical programs focused on protein degraders for acute myeloid leukemia and...

Sanofi signed a discovery and development collaboration with AI‑driven Earendil Labs focused on bispecific antibodies for autoimmune and inflammatory diseases, a pact valued up to $2.56 billion....

Eli Lilly extended its collaboration with Nimbus Therapeutics to develop an oral obesity therapy, committing $55 million in upfront and near‑term payments and potential downstream milestones that...